DOLPHIN BIOLOGY RESEARCH INSTITUTE
Balance Sheet
Fiscal Year Start:
Jan 1
Data visualization unavailable
Assets in 2024 (Year End)
$902,215
Cash & Equivalents
51%
Investments
35%
Property, Plant, & Equipment (net)
9%
Other Assets
5%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Liabilities in 2024 (Year End)
$0
Payables & Accruals
N/A
Grants Payable
N/A
Deferred Revenue
N/A
Tax-Exempt Bond Liabilities
N/A
Custodial & Escrow Liabilities
N/A
Notes Payable / Debt (Non-Related)
N/A
Related-Party Payables
N/A
Other Liabilities
N/A
Assets
2023
2024
Change
Cash & Equivalents
$396,106
$461,325
+16%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$208,579
$318,879
+53%
Property, Plant, & Equipment (net)
$75,942
$80,011
+5%
Other Assets
$42,000
$42,000
+0%
Total Assets
$722,627
$902,215
+25%
Liabilities
2023
2024
Change
Payables & Accruals
-
-
-
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$0
$0
-
Net assets
2023
2024
Change
Restricted Net Assets
N/A
N/A
N/A
Unrestricted Net Assets
N/A
N/A
N/A
Net assets
2023
2024
Change
Net assets
+$722,627
+$902,215
+25%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)